Also trades as: HX (NASDAQ) · $vol 7M
AHG NASDAQ
Akso Health Group
1W: +53.3%
1M: +35.3%
3M: -24.8%
YTD: -28.1%
1Y: -31.6%
3Y: +12.8%
5Y: -37.8%
$1.15
+0.13 (+12.75%)
Weekly Expected Move ±20.7%
$1
$1
$1
$1
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$13M
-1186.6% ▼
Capital Expenditures
$176M
-113629.2% ▼
Free Cash Flow
-$188M
-18527.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$176M
-295.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$17M | -$13M | -$9M | -$135M | -$19M |
| Depreciation & Amort. | $18K | $0 | $0 | $2M | $2M |
| Stock-Based Comp. | $392K | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$3M | -$1M | $2M | $3M | -$11M |
| Other Non-Cash Items | $10M | $11M | $8M | $162M | $17M |
| Operating Cash Flow | -$9M | -$3M | $1M | $1M | -$13M |
| — Investing Activities — | |||||
| Capital Expenditures | -$5K | $0 | $0 | -$154K | -$2K |
| Acquisitions (Net) | $0 | $0 | $0 | -$94M | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$20M | $18M | -$55M | -$12M | -$163M |
| Investing Cash Flow | -$20M | $18M | -$55M | -$106M | -$163M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$10M | -$28M | -$8M | $0 | $350K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $35M | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $35M | -$28M | $132M | $196M | $350K |
| Net Change in Cash | $7M | -$13M | $77M | $90M | -$176M |
| Cash End of Period | $22M | $9M | $86M | $176M | $171K |
| Free Cash Flow | -$9M | -$3M | $1M | $1M | -$188M |